Syndrome des jambes sans repos chez la personne âgée: une affection méconnue [Restless legs syndrome in the elderly: an unrecognized disorder].

Détails

Ressource 1Télécharger: RMS_idPAS_D_ISBN_pu2008-40s_sa03_art03.pdf (226.90 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_239D5E53DD1B
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Syndrome des jambes sans repos chez la personne âgée: une affection méconnue [Restless legs syndrome in the elderly: an unrecognized disorder].
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Biselx S., Büla C., Ghika J.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2008
Peer-reviewed
Oui
Volume
4
Numéro
178
Pages
2382-2386
Langue
français
Résumé
The restless legs syndrome (RLS) is a frequent, often unrecognized disorder in the elderly. The diagnosis is essentially based on the clinical history. The RLS is characterized by (1) an urge to move the limbs, usually associated with abnormal sensations in the legs; (2) symptoms are worse at rest; (3) they are relieved by movements; (4) they mainly occur in the evening or at night. Specific diagnostic criteria have been developed for cognitively impaired elderly persons. The RLS is a chronic disorder with high impact on sleep and quality of life. Treatment is symptomatic and recommended drugs are dopaminergic agents, opioids, and gabapentine.
Mots-clé
Aged, 80 and over, Alzheimer Disease/complications, Amines/therapeutic use, Anticonvulsants/therapeutic use, Benzodiazepines/therapeutic use, Cyclohexanecarboxylic Acids/therapeutic use, Diagnosis, Differential, Dopamine Agents/therapeutic use, Female, Humans, Narcotics/therapeutic use, Quality of Life, Restless Legs Syndrome/complications, Restless Legs Syndrome/diagnosis, Sleep Disorders/etiology, Tranquilizing Agents/therapeutic use, gamma-Aminobutyric Acid/therapeutic use
Pubmed
Création de la notice
04/09/2011 15:04
Dernière modification de la notice
15/10/2024 6:26
Données d'usage